{
    "doi": "https://doi.org/10.1182/blood.V118.21.3368.3368",
    "article_title": "Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER, ",
    "article_date": "November 18, 2011",
    "session_type": "401. Basic Science and Clinical Practice in Blood Transfusion: Poster III",
    "abstract_text": "Abstract 3368 Introduction Patients with an inherited factor VII (FVII) deficiency may display a wide range of clinical phenotypes, from an asymptomatic condition to serious hemorrhagic episodes such as fatal central nervous system (CNS) or gastrointestinal (GI) bleeds (Mariani G et al. Thromb Haemost 2005; 93: 481\u20137). Symptomatic patients can be divided into two major categories: those with mild-to-moderate bleeding tendency and individuals with a severe bleeding tendency which may be more severe than that in hemophilia. The former group mainly experience mucosal bleeding, a clinical picture that mimics that of a platelet disorder and often does not call for treatment. In contrast, for the most severely affected patients, characterized by life- or limb-threatening hemorrhages, more aggressive Replacement Therapy (RT) as long or short-term prophylxis may be required. Aim Within the frame of the Seven Treatment Evaluation Registry we have prospectively collected large numbers of treatments for spontaneous bleeding episodes and evaluted schedules and side-effects. Clinicaltrials.gov identifier: NCT01269138 . Results As of May 2011, 64 evaluable spontaneous bleedings (managed in 16 haemophilia treatment centres, 11 countries), were observed in 40 FVII-deficient subjects (25 females and 15 males) with residual FVII coagulant activity (FVIIc) levels between <1% and 20% (90% of patients had FVIIc below 5% of normal). Bleeding episodes were grouped into the following categories: 1. CNS + GI (n=2+4), 2. Hemarthroses (n=23), 3. Muscle hematomas (n=6), Epistaxis (n=4), Gum bleeding (n=7), Menorrhagia (n=11), Other (n=7) (hemorrhoidal n=2, subcutaneous hematomas n=2, easy bruising n=1, hematuria n=1, hemoperitoneum n=1). Recombinant FVIIa was given to treat 47 episodes, plasma derived FVII (pdFVII) concentrates 7, Prothrombin Complex Concentrate (PCC) 3 and Fresh Frozen Plasma (FFP) 7 ( Table 1 ). No thrombosis episodes were reported during the thirty-day follow up. Table 1 Type of Bleeding, Replacement Therapy (RT) schedules and outcome  Bleeds . n . RT . RT days . n. of doses . Total dose range (\u03bcg/Kg IU/Kg ml/Kg) . Outcome . CNS & GI 6 rFVIIa 3 1\u20134 1\u20138 rFVIIa 160-240 median 160 Excellent 1 P.Effective 2 pdFVII 2 pdFVII 15-60 \u2013 P.Effective 1 Effective 1 FFP 1 FFP 2 \u2013 Effective 1 Hemarthrosis 23 rFVIIa 22 1\u20132 1\u20137 rFVIIa 18 \u2013 1100 60 Excellent 19 Effective 3 PCC 1 PCC 38 \u2013 Excellent 1 Hematomas (muscle & subcut.) 8 rFVIIa 4 1\u20136 1\u201312 rFVIIa 54- 80 66 Excellent 3 Effective 1 pdFVII 1 pdFVII 56 \u2013 Excellent 1 PCC 2 PCC 30 \u2013 Excellent 1 n.e. 1 FFP 1 FFP 72 \u2013 Effective 1 Menorrhagia 11 rFVII 10 1\u20136 1\u20138 rFVII 20 \u2013 120 41 Excellent 5 Effective 5 pdFVII 1 pdFVII 135 Effective 1 Epistaxis & Gum bleeding 12 rFVIIa 5 1 1\u20133 rFVIIa 27- 180 71 Excellent 4 Effective 1 pdFVII 4 pdFVII 21-56 44 Excellent 3 Effective 1 FFP 3 FFP 1.8-12 2.6 Effective 3 Other 5 rFVIIa 3 1-11 1-52 rFVIIa 33-1716 \u2020  33 Excellent 1 Effective 2 pdFVII 1 pdFVII 18 \u2013 Excellent 1 FFP 1 FFP 31 \u2013 P.Effective 1 Bleeds . n . RT . RT days . n. of doses . Total dose range (\u03bcg/Kg IU/Kg ml/Kg) . Outcome . CNS & GI 6 rFVIIa 3 1\u20134 1\u20138 rFVIIa 160-240 median 160 Excellent 1 P.Effective 2 pdFVII 2 pdFVII 15-60 \u2013 P.Effective 1 Effective 1 FFP 1 FFP 2 \u2013 Effective 1 Hemarthrosis 23 rFVIIa 22 1\u20132 1\u20137 rFVIIa 18 \u2013 1100 60 Excellent 19 Effective 3 PCC 1 PCC 38 \u2013 Excellent 1 Hematomas (muscle & subcut.) 8 rFVIIa 4 1\u20136 1\u201312 rFVIIa 54- 80 66 Excellent 3 Effective 1 pdFVII 1 pdFVII 56 \u2013 Excellent 1 PCC 2 PCC 30 \u2013 Excellent 1 n.e. 1 FFP 1 FFP 72 \u2013 Effective 1 Menorrhagia 11 rFVII 10 1\u20136 1\u20138 rFVII 20 \u2013 120 41 Excellent 5 Effective 5 pdFVII 1 pdFVII 135 Effective 1 Epistaxis & Gum bleeding 12 rFVIIa 5 1 1\u20133 rFVIIa 27- 180 71 Excellent 4 Effective 1 pdFVII 4 pdFVII 21-56 44 Excellent 3 Effective 1 FFP 3 FFP 1.8-12 2.6 Effective 3 Other 5 rFVIIa 3 1-11 1-52 rFVIIa 33-1716 \u2020  33 Excellent 1 Effective 2 pdFVII 1 pdFVII 18 \u2013 Excellent 1 FFP 1 FFP 31 \u2013 P.Effective 1 * patient treated for severe hemoperitoneum; P.Effective:Partly Effective; n.e.: not evaluable View Large Conclusion Treatment schedules and outcomes depend on the clinical setting. As for the severest bleeds (CNS and GI), on demand RT is probably not the best choice and prophylaxis should be considered as first line option especially in babies and children. Hemarthroses can be successfully treated for one day only; the number of doses used vary (from 1 to 7) as variable is the total dose of rFVIIa (from 35 to 210 \u03bcg/Kg/bw, mean 73.7, median 60) but an average intermediate dose of 60 \u03bcg/Kg/bw, possibly split in two doses, seems appropriate. The same holds for muscle and subcutaneous hematomas, always with one-day treatment schedule. RT protocols for menorrhagia varied either in terms of duration or rFVIIa total dose (1 to 6 days, total rFVIIa dosing ranging from 20 to 135 \u03bcg/Kg/bw, mean 88, median 40); treatment duration, however, did not appear to influence the outcome as one day RT showed the same efficacy as multiple days schedules. Successful RT for gum bleeding and epistaxis required treatment for one day only with doses of rFVIIa ranging from 27 to 180 \u03bcg/Kg/bw (mean 87.8, median 71) and of pdFVII ranging from 21 to 56 IU/Kg/bw (mean 41.5, median 44.5). Others bleed management were reported (hemorrhoidal, hematuria, easy bruising, peritoneal bleeding) but numbers do not allow to draw any conclusion as is the case for treatments carried out with FFP and PCCs. Disclosures: Knudsen: Novonordisk: Employment.",
    "topics": [
        "factor vii deficiency",
        "hemorrhagic episodes",
        "recombinant coagulation factor viia",
        "fresh-frozen plasma",
        "concentrate dosage form",
        "epistaxis",
        "gingival hemorrhage",
        "hemarthrosis",
        "hematoma",
        "hemoperitoneum"
    ],
    "author_names": [
        "Mariasanta Napolitano, MD",
        "Alberto Dolce, PhD",
        "Angelika Batorova, MD, PhD",
        "Guenter K.H. Auerswald, MD",
        "Jean-Francois Schved",
        "Sergio Siragusa, MD",
        "Jens Bjerre Knudsen, MD, PhD",
        "Jorgen Ingerslev",
        "Carmen Altisent, MD",
        "Kaan Kavakli, MD",
        "Umran Caliskan",
        "Tahir S Shamsi, MD",
        "Marie Bertrand, MD",
        "Sophie Aronis, MD",
        "Giovanni Di Minno",
        "Arlette Ruiz-Sa\u0301ez, MD",
        "Ampaiwan Chuansumrit",
        "Rosario Perez Garrido, MD",
        "Kanjaksha Ghosh",
        "Narges Mirbehbahani, MD",
        "Mehran Karimi, MD",
        "Guglielmo Mariani, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Mariasanta Napolitano, MD",
            "author_affiliations": [
                "Hematology, Lombardi Comprehensive Cancer Center, Washington DC, DC, USA, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Alberto Dolce, PhD",
            "author_affiliations": [
                "National Institute of Statistics, Palermo, Italy, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angelika Batorova, MD, PhD",
            "author_affiliations": [
                "National Hemophilia Center, Bratislava, Slovak Republic, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guenter K.H. Auerswald, MD",
            "author_affiliations": [
                "Klinikum Bremen-Mitte, Bremen, Italy, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jean-Francois Schved",
            "author_affiliations": [
                "Laboratoire d'hematologie, Hospital Saint Eloi, Montpellier, France, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sergio Siragusa, MD",
            "author_affiliations": [
                "Cattedra ed U.O. di Ematologia, Universita\u0300 degli Studi di Palermo, Palermo, Italy, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jens Bjerre Knudsen, MD, PhD",
            "author_affiliations": [
                "Medical and Science Haematology, Novo Nordisk, Copenaghen, Denmark, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jorgen Ingerslev",
            "author_affiliations": [
                "Skejby University Hospital, Centre for Haemophilia and Thrombosis, Aarhus, Denmark, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carmen Altisent, MD",
            "author_affiliations": [
                "Hospital Universitari Vall d'Hebron, Barcelona, Spain, "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kaan Kavakli, MD",
            "author_affiliations": [
                "Ege University Hospital, IZMIR, Turkey, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Umran Caliskan",
            "author_affiliations": [
                "Selcuk University Meram Medical Faculty Pediatric Hematology Department, Konia, Turkey, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tahir S Shamsi, MD",
            "author_affiliations": [
                "Hematology, National Institute of Blood Diseases, Karachi, Pakistan, "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marie Bertrand, MD",
            "author_affiliations": [
                "CRTH de Besanc\u0327on, Besanc\u0327on, France, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sophie Aronis, MD",
            "author_affiliations": [
                "Haemophilia Centre-Haemostasis Unit, Athens, Greece, "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giovanni Di Minno",
            "author_affiliations": [
                "Centro Rif. Reg.Emocoagulopatie Univ. Federico II, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Arlette Ruiz-Sa\u0301ez, MD",
            "author_affiliations": [
                "Centro Nacional de Hemofilia, Caracas, Venezuela, "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ampaiwan Chuansumrit",
            "author_affiliations": [
                "Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rosario Perez Garrido, MD",
            "author_affiliations": [
                "Virgen del Roci\u0301o, Sevilla, "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kanjaksha Ghosh",
            "author_affiliations": [
                "Institute of Immunohematology, Mumbai, India, "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Narges Mirbehbahani, MD",
            "author_affiliations": [
                "heamophilia and thalassemia research center, Telengani, Iran, "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mehran Karimi, MD",
            "author_affiliations": [
                "Shiraz university of Medical Sciences, Shiraz, "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guglielmo Mariani, MD",
            "author_affiliations": [
                "Internal Medicine & Public Health, University of L'Aquila, L'Aquila, Italy"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-18T02:16:07",
    "is_scraped": "1"
}